RCUS Return on Tangible Equity | Arcus Biosciences, Inc.

Arcus Biosciences, Inc. (RCUS) Return on Tangible Equity

2026-06-30: Return Tang Equity -99.14%.
2026-03-31: Return Tang Equity -70.42%.
2025-12-31: Return Tang Equity -55.94%.
2025-09-30: Return Tang Equity -78.21%.

Complete source-backed return tang equity history.

Available history: 2016-12-31 to 2026-06-30
Data captured: 2026-09-04

Historical Return Tang Equity

Date	Return Tang Equity
2026-06-30	-99.14%
2026-03-31	-70.42%
2025-12-31	-55.94%
2025-09-30	-78.21%
2025-06-30	-54.28%
2025-03-31	-73.63%
2024-12-31	-58.35%
2024-09-30	-47.79%
2024-06-30	-39.21%
2024-03-31	-32.67%
2023-12-31	-66.45%
2023-09-30	-56.35%
2023-06-30	-50.71%
2023-03-31	-46.50%
2022-12-31	-40.64%
2022-09-30	11.38%
2022-06-30	8.91%
2022-03-31	7.23%
2021-12-31	6.29%
2021-09-30	-51.33%
2021-06-30	-32.87%
2021-03-31	-25.25%
2020-12-31	-24.50%
2020-09-30	-16.09%
2020-06-30	-26.07%
2020-03-31	-67.40%
2019-12-31	-51.65%
2019-09-30	-45.37%
2019-06-30	-35.02%
2019-03-31	-24.51%
2018-12-31	-21.11%
2018-09-30	-20.61%
2018-06-30	-24.68%
2018-03-31	-22.07%
2017-12-31	73.39%

Annual Return Tang Equity

Date	Return Tang Equity
2025-12-31	-55.94%
2024-12-31	-58.35%
2023-12-31	-66.45%
2022-12-31	-40.64%
2021-12-31	6.29%
2020-12-31	-24.50%
2019-12-31	-51.65%
2018-12-31	-21.11%
2017-12-31	73.39%
2016-12-31	89.88%

Similar stocks

Stock Name	Country	Market Cap	PE Ratio
Dyne Therapeutics, Inc. (DYN)	United States	$3.084B	-7.09
Arcutis Biotherapeutics, Inc. (ARQT)	United States	$3.303B	115.47
Enliven Therapeutics, Inc. (ELVN)	United States	$3.307B	-35.07
Amylyx Pharmaceuticals, Inc. (AMLX)	United States	$3.361B	-13.15
IDEAYA Biosciences, Inc. (IDYA)	United States	$3.540B	-20.52
Organon & Co. (OGN)	United States	$3.603B	17.03
PRECIGEN, INC. (PGEN)	United States	$2.757B	-12.94
NewAmsterdam Pharma Co N.V. (NAMS)		$2.719B	-15.37
Xenon Pharmaceuticals Inc. (XENE)		$3.684B	-14.27
MBX Biosciences, Inc. (MBX)	United States	$2.664B	-25.36